NASH, or nonalcoholic steatohepatitis, is a liver condition that often goes unnoticed for years. However, it should not be taken lightly as it gradually worsens and can eventually lead to cirrhosis, a severe liver disease. Cirrhosis from NASH is becoming increasingly prevalent in the United States and is now one of the main causes of adult cirrhosis. This underscores the importance of early detection and appropriate medical management, which can help prevent further liver damage and the progression of the disease. If you suspect that you may be at risk for NASH, it is critical to speak with your healthcare provider and take the necessary steps to safeguard your liver health.

Join Encore Borland Groover Clinical Research (EBGCR) for a complimentary Fibroscan test for fatty liver. Be sure to take advantage of this opportunity to assess your liver health and take control of your well-being.

Physician Investigator

NIKHIL KAPILA, MD

Gastroenterologist Borland Groover

Work Phone: 904-680-0871work

Learn more about this investigational treatment option for Itching from Urticaria or Chronic Spontaneous Urticaria ( CSU)

CSU is a skin condition that is characterized by transient and unpredictable itchy, red bumps on skin. CSU occurs spontaneously without a known cause.

The MAVERICK clinical study is examining a new investigational treatment option for Chronic Spontaneous Urticaria (CSU). Urticaria consists of itchy, red bumps on the skin that appear and disappear abruptly, with no known cause or trigger. The injections given subcutaneously under this study could offer a new avenue of relief for those with this uncomfortable condition. As the results of the study become available, they could have significant implications on how CSU is managed going forward, and provide much needed relief to people all over the world who are struggling with Urticaria.

Contact Research

Raquel Watkins, MD, MS

Encore Borland Groover Clinical Research (EBGCR)

Contact Research: 9046800871

Notes

 

 

Liquid Biopsy to Detect Early Stage Colorectal Cancer

In a world where colorectal cancer is the second leading cause of death, it’s important to have new ways that can help detect and treat these diseases early on. One such technique would be liquid biopsy- an innovative form of testing blood samples for signs of cancer.

Contact Research

Physician Investigator

Bharat K Misra, MD

Gastroenterologist and Research Director Encore Borland Groover Clinical Research (EBGCR)

4800 Belfort Road Jacksonville FL 32256 postal Contact Research: 9046800871 Research Email: BMisra@encoredocs.comINTERNET

Hepatocellular carcinoma is the most common form of liver cancer.  The risk of hepatocellular carcinoma, the most common type of liver cancer, is higher in patients with long-term liver diseases. It is a serious illness that can be life-threatening.

Learn more about a clinical trial for Heptocellular Carcinoma
Contact Research

Early CRC detection saves lives.

Are you due for your next colonoscopy within the next 90 days? Join this study to help us develop a blood test that accurately and easily detects colorectal cancer (CRC). According to the CDC, early detection can dramatically improve survival rates. That’s why we are looking to validate a simple blood test for early CRC detection.

Contact Research

Physician Investigator

Bharat K Misra, MD

Gastroenterologist and Research Director Encore Borland Groover Clinical Research (EBGCR)

4800 Belfort Road Jacksonville FL 32256 postal Contact Research: 9046800871 Research Email: BMisra@encoredocs.comINTERNET

Hepatitis C virus is most often transmitted through exposure to infected blood. Most people have no symptoms. Those who do develop symptoms may have fatigue, nausea, loss of appetite, and yellowing of the eyes and skin.
Hepatitis C is treated with antiviral medications. In some people, newer medicines can eradicate the virus.

Pill Cam Device can aid in the early detection of disorders

During a capsule endoscopy procedure, the patient will swallow a tiny camera that’s about the size of a large vitamin pill. The Pillcam is a capsule you swallow is  designed to examine the small bowel. The PillCam SB system is an ingestible capsule the size of a vitamin. It contains a tiny camera and light source that takes pictures of your small intestine as it travels naturally through your digestive tract. It takes 2 to 6 images per second, generating anywhere from 57,600 to 172,800 pictures in an eight-hour period. The images are then transmitted to a recorder that you wear on a strap across your body. Sensors placed on your stomach or in a sensor belt help transmit these images.

PillCam can aid in the early detection of disorders of the small intestine such as Crohn’s disease, iron deficiency anemia, small bowel tumors, and celiac disease.

Physician Investigator

Mark Fleisher, MD

Gastroenterologist Encore Borland Groover Clinical Research

4800 Belfort Road Jacksonville FL 32256 postal Contact Research: 9046800871 Research Email: MFleisher@encoredocs.comINTERNET

NERD Non-Erosive Gastroesophageal Reflux Disease

Do you experience symptoms like heartburn, regurgitation, or difficulty swallowing? You may have gastroesophageal reflux disease (GERD), a condition where stomach acid flows back into the esophagus. But if you have these symptoms without any visible damage to the esophageal mucosal lining, you may have non-erosive gastroesophageal reflux disease (NERD).

Doctors can diagnose NERD with an endoscopy, where a camera is inserted into the esophagus to examine the tissue. If there is no damage to the esophageal lining, you may be diagnosed with NERD. It’s worth noting that NERD can range from mild to severe symptoms.

Research shows that around 50-85% of people with reflux-related symptoms but negative endoscopic findings are diagnosed with NERD. And more than two-thirds of all GERD patients have NERD. Accurate diagnosis and appropriate treatment for NERD are crucial to managing symptoms and preventing complications.

Don’t let NERD affect your quality of life. Talk to your doctor and contact Encore Borland Groover Clinical Research (EBGCR) to learn more about clinical trials for persistent reflux-related symptoms.

Contact Research

Physician Investigator

Bharat K Misra, MD

Gastroenterologist and Research Director Encore Borland Groover Clinical Research (EBGCR)

4800 Belfort Road Jacksonville FL 32256 postal Contact Research: 9046800871 Research Email: BMisra@encoredocs.comINTERNET

The most common symptoms of esophagitis are heartburn, chest pain and dysphagia (trouble swallowing). If you have been diagnosed with or suspect you may have erosive esophagitis please contact us to learn more about current clinical trials.

A Phase 3, Randomized, Double-Blind, Two-Phase, Multicenter Study to Evaluate the Efficacy and Safety of Vonoprazan 20 mg Compared to Lansoprazole 30 mg for Healing in Patients with Erosive Esophagitis and to Evaluate the Efficacy and Safety of Vonoprazan (10 mg and 20 mg) Compared to Lansoprazole 15 mg for the Maintenance of Healing in Patients with Healed Erosive Esophagitis PROTOCOL NO. EE-301

Bharat K Misra, MD

Gastroenterologist and Research Director Encore Borland Groover Clinical Research (EBGCR)

4800 Belfort Road Jacksonville FL 32256 postal Contact Research: 9046800871 Research Email: BMisra@encoredocs.comINTERNET